1. Unlocking New Diagnostic Tools from Diabetes

    In today’s modern world, the recent dramatic increase in the number of patients with type 2 diabetes indicates an unchecked global epidemic is at hand. In 2011 the U.S. Centers for Disease Control and Prevention estimated that about 8.3% of the American population (25.8 million people) had diabetes—while 7 million were unaware of it.
  2. Novel Class of Anti-Diabetic Drug to Assist Type 2 Diabetics

    Research shows us that patients with type 2 diabetes mellitus (T2DM) have an impaired incretin secretion response to glucose. This finding has encouraged the development of a new class of anti-diabetic drugs classified as incretin-based therapy [1].

2 Item(s)

To Top